Metraipolis › archive › dc_e2a3592cb6e2
The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells — Europe PMC PMID:39796712
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39796712
- DOI
- 10.3390/cancers17010081
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T06:34:56.029Z
- SHA-256 of the archived text
6b814e27bea909a5189b6d2d0f715137ff21e28aaac608c66ed6f6d4d6d826fd- Stable URL of this page
https://metraipolis.com/documento/dc_e2a3592cb6e2
How to cite
The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells — Europe PMC PMID:39796712 — Europe PMC (en), https://europepmc.org/article/MED/39796712 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2a3592cb6e2 (Metraipolis archive dc_e2a3592cb6e2, sha256 6b814e27bea909a5189b6d2d0f715137ff21e28aaac608c66ed6f6d4d6d826fd)
BibTeX
@misc{dce2a3592cb6e2,
title = {The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells — Europe PMC PMID:39796712},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39796712},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2a3592cb6e2; sha256 6b814e27bea909a5189b6d2d0f715137ff21e28aaac608c66ed6f6d4d6d826fd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39796712. Agents can read the archived copy with the MCP tool read_document.